Dasatinib-d8

• CAT Number: S000170
• CAS Number: 1132093-70-9
• Molecular Formula: C22H18D8ClN7O2S
• Molecular Weight: 496.05
• Purity: ≥95%
• Target: Apoptosis
• IUPAC Name: N-(2-chloro-6-methylphenyl)-2-[[2-methyl-6-[2,2,3,3,5,5,6,6-octadeuterio-4-(2-hydroxyethyl)piperazin-1-yl]pyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
• InChI: InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)/i6D2,7D2,8D2,9D2
• InChIKey: ZBNZXTGUTAYRHI-COMRDEPKSA-N
• SMILES: [2H]C1(C(N(C(C(N1CCO)([2H])[2H])([2H])[2H])C2=NC(=NC(=C2)NC3=NC=C(S3)C(=O)NC4=C(C=CC=C4Cl)C)C)([2H])[2H])[2H]

Dasatinib-d8, a premium pharmaceutical research compound designed for advanced oncology and kinase inhibitor studies. As a deuterated analog of Dasatinib, it offers enhanced stability and improved pharmacokinetic properties. Dasatinib-d8 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for chronic myeloid leukemia (CML) and other cancers. Trusted by leading laboratories, Dasatinib-d8 is your go-to solution for cutting-edge cancer research. Unlock new possibilities in cancer treatment with Dasatinib-d8, where innovation meets reliability.